Stock_Titan Posted - 2 days ago

$BIO $BIOB Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 https://www.stocktitan.net/news/BIO/bio-rad-to-report-first-quarter-2024-financial-results-on-tuesday-an3czfafv34l.html

Noobnioo Posted - 2 days ago

$BIO Buy adpt stock. Now best price. $riot $mara $PYPL is fall.

Bgarr231 Posted - 6 days ago

$BIO why is this down so much ?

OpenOutcrier Posted - 1 week ago

$OCX (+13.8% pre) Oncocyte and $BIO Bio-Rad Partner on Global Launch of Transplant Assay - SI https://ooc.bz/l/30223

matthew122 Posted - 1 week ago

$BIO partnership with $OCX to launch their pcr diagnostic kit. Everyone should check it out. Good chance to get in early with Biorad.

Stock_Titan Posted - 1 week ago

$BIO Bio-Rad’s Chief Operating Officer Andrew Last to Retire https://www.stocktitan.net/news/BIO/bio-rad-s-chief-operating-officer-andrew-last-to-xzqh07gaev06.html

Alex_Hudson Posted - 1 week ago

$BIO RSI Cross Above 50 Level.

d1dan Posted - 2 weeks ago

$BIO https://www.globenewswire.com/news-release/2020/12/03/2139086/0/en/Enlivex-Reports-Positive-Interim-Results-From-Phase-II-Clinical-Trial-Evaluating-Allocetra-in-Severe-and-Critical-COVID-19-Patients.html

TickerDD_com Posted - 03/21/24

From 3/12/2024, looking back across 22 Month-Ends for BIO, Percentage Change of Average Monthly Price had More Positives (55%) while Percentage Change of Average Monthly Volume had More Positives (95%) $BIO #BIO #BIOStock #TickerDD https://www.youtube.com/watch?v=BroWNPzZvDA

EmmaRespond Posted - 1 month ago

Investing in Bio-Rad Laboratories, Inc. - Why You Should Consider Buying the $BIO Stock http://dlvr.it/T4LSTS

HeavyLift Posted - 1 month ago

$BIO 👀

d1dan Posted - 1 month ago

$BIO must come to ENLV 🚀🚀

TogetherWeRally Posted - 1 month ago

$TCBP and $BIO next!

DavidUpla Posted - 1 month ago

$BIO $MDT $MRK $PFE $LVTX https://www.globenewswire.com/news-release/2024/01/25/2816550/0/en/LAVA-Therapeutics-Announces-Collaboration-with-Merck-Co-Inc-Rahway-NJ-USA-to-Evaluate-LAVA-1207-in-Combination-with-KEYTRUDA.html

DavidUpla Posted - 1 month ago

$LVTX $PFE $MRK $MDT $BIO “We (LVTX) are excited to work with Merck & Co., Inc., Rahway, NJ, USA as we continue to unlock the therapeutic potential of LAVA-1207 and explore its potential capabilities in combination with KEYTRUDA®,” said Stephen Hurly, President and Chief Executive Officer, LAVA. “To date, LAVA-1207 has demonstrated a favorable safety profile and shown preliminary signs of anti-tumor activity.

insiderbuyingselling Posted - 02/28/24

$BIO BIOB new insider selling: 3000 shares. http://insiderbuyingselling.com/?t=BIO BIOB

smartkarma Posted - 02/26/24

$BIO | Bio Rad Laboratories: Initiation of Coverage - Unveiling the Future - Next-Gen Products That Will Skyrocket Your Portfolio! - Major Drivers "This is our first report on life science research and clinical diagnostic products manufacturer, Bio- Rad Laboratories. The company's results..." - Baptista Research (Baptista Research) Key Points:This is our first report on life science research and clinical diagnostic products manufacturer, Bio- Rad Laboratories.The company's results exhibit resilience with substantial room for improvements and growth in the coming years.Bio-Rad's FY 2023 net sales of $2.671 billion reflect a decrease by 4.7% on a reported basis as compared to 2022. Read more: https://www.smartkarma.com/insights/bio-rad-laboratories-initiation-of-coverage-unveiling-the-future-next-gen-products-that-will-skyrocket-your-portfolio-major-drivers

Cal1f0rn1aBay Posted - 02/26/24

$LEAS merging with $RWOD Redwoods Acquisition for $60 mil $BLUE $BIO Going straight to Nasdaq

Stock_Titan Posted - 02/22/24

$BIO Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day https://www.stocktitan.net/news/BIO/bio-rad-to-participate-in-fireside-chat-during-citi-s-2024-unplugged-aizlflx1z8g6.html

DDGuy3040 Posted - 1 month ago

$CPOP check out $BIO

Fullratio Posted - 1 month ago

$BIO operating income is down by 30% year-on-year and by 6% since the previous quarter: https://fullratio.com/stocks/nyse-bio/bio-rad-laboratories

win_condition Posted - 2 months ago

$BFRG $BIO are these two related?

win_condition Posted - 2 months ago

$BIO not sure why this is on my watchlist, but are the options cheap for the volatility?

swingingtech Posted - 2 months ago

$MCD $BIO $DLTR https://wallstreetwaves.com/noteworthy-friday-option-activity-mcd-bio-dltr/

swingingtech Posted - 2 months ago

$VMC, $ALB, $XLB, $BIO https://wallstreetwaves.com/friday-sector-leaders-materials-healthcare/

Thestocktraderhubzee Posted - 2 months ago

$BIO RBC Capital Maintains Outperform on Bio-Rad Laboratories, Lowers Price Target to $480

epsguid Posted - 2 months ago

$BIO reported earnings of $3.10, consensus was $2.93 via @eWhispers #epsbeat http://eps.sh/d/bio

DonCorleone77 Posted - 2 months ago

$BIO Bio-Rad sees FY24 revenue up 1%-2.5% Implies $2.70B-$2.74B, consensus $2.71B. Sees operating margin of approximately 13.5% to 14.0% vs. 14.2% in FY23.

DonCorleone77 Posted - 2 months ago

$BIO Bio-Rad reports Q4 EPS $3.10, consensus $2.82 Reports Q4 revenue $681.2M, consensus $685.1M. "The ongoing weakness in biopharma markets continued to impact our fourth-quarter 2023 results, which were largely in line with expectations," said Norman Schwartz, CEO. "Shifting focus to 2024, our full-year outlook reflects ongoing execution of our corporate transformation initiatives, effective expense management, and a cautiously optimistic view of a gradual biopharma sector recovery in the second half of the year," Mr. Schwartz continued. "We also recognize the efforts of our global employees, whose ongoing dedication and commitment to our customers' success helped us navigate the challenges of 2023."

1986iamwallstreet Posted - 2 months ago

$BIO Bio-Rad Laboratories Q4 2023 Adj EPS $3.10 Beats $2.82 Estimate, Sales $681.20M Miss $685.09M Estimate